← Back to guidelines
Neurology46 papers

Mild neurocognitive disorder

Last edited: 4/10/2026

Overview

Mild neurocognitive disorder (mild NCI) is a condition characterized by cognitive decline that is noticeable but does not interfere with independence in daily activities. Individuals with mild NCI have an increased risk of progressing to dementia.

Diagnosis

  • Cognitive markers in the mild NCI stage are debated in their ability to predict dementia occurrence and incidence 1.
  • Specific cognitive domains assessed include global cognitive functioning, long-term verbal memory, complex attention, visuoconstructional ability, and language 1.
  • Management

  • Interventions aimed at preserving or enhancing long-term verbal memory, visuoconstructional abilities, and language skills may be beneficial in delaying or preventing dementia onset 1.
  • Key Recommendations

  • Better performance in long-term verbal memory, visuoconstructional abilities, and language in individuals with mild NCI is associated with a lower risk of progression to dementia 1. (Evidence: Moderate)
  • Interventions targeting the preservation or enhancement of specific cognitive domains (long-term verbal memory, visuoconstructional ability, language) may serve as potential therapeutic targets for clinicians working with at-risk populations 1. (Evidence: Weak)
  • References

    1 Raimo S, Gaita M, Cropano M, Ammendola L, Malangone D, Torchia V et al.. Cognitive markers of resilience to dementia in mild Neurocognitive Impairment: a meta- analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025. link

    Original source

    1. [1]
      Cognitive markers of resilience to dementia in mild Neurocognitive Impairment: a meta- analysis.Raimo S, Gaita M, Cropano M, Ammendola L, Malangone D, Torchia V et al. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025)
    2. [2]
      Neuroscience training in the USA and Canada: observations and suggestions.Zigmond MJ, Spear LP Trends in neurosciences (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG